Trial Profile
Quality of recovery after elective surgery using neostigmine or sugammadex as neuromuscular blockade reversal agents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 16 Dec 2015 New trial record